NCI CIRB Information About COVID-19

On April 10, 2023, President Biden signed the bill officially ending the COVID-19 national emergency for the United States. All allowed COVID-19 deviations and reporting requirements are now discontiunued.

The following section will be retained for archival purposes.



The NCI CIRB is monitoring the COVID-19 (coronavirus) outbreak and is working closely with NCI as new information arises. Currently, the NCI CIRB is fully functional and operating at our standard capacity. We do not anticipate any negative impacts on our procedures or timelines due to the outbreak.  

This page will be used a central location for all COVID-19 related announcements that pertain to the NCI CIRB, covered clinical studies, or stakeholder responsibilities. It has been developed as a single collection point for all COVID-19 information to help the research community when addressing the outbreak of COVID-19 within the context of CIRB approved clinical trials. Please refer to this page daily to keep apprised of COVID-19 developments and announcements.  

Additional information is available on the CTSU website.  Announcements from NCI and the LPOs will be posted as they are received. Check the News & Announcements section for messages and a link to the COVID-19 Information page (login to members’ website required). 

Additional information from NCI is also available on the CTEP homepage.


Updated April 17, 2023